News Focus
News Focus
Followers 1
Posts 836
Boards Moderated 0
Alias Born 03/30/2007

Re: keep_trying post# 12802

Sunday, 04/01/2007 10:27:40 AM

Sunday, April 01, 2007 10:27:40 AM

Post# of 347009
Thank you, KT. What became of Oncolym and Schering trials?

Also note this from 2001 Fool article. Is he gone now?:
>The company has an agreement with a Chinese drug company called Brilliance Pharmaceuticals, which owns the product rights to Cotara in China. This deal was done through a third company called Cancer Therapeutics, to which Peregrine granted an exclusive right to sublicense in China for ten years. But investors should note that this is a related party transaction. According to last year's 10-K filing, Dr. Clive Taylor, who is an officer, director, and 26% owner of Cancer Therapeutics, is also a member of the board of directors of Peregrine Pharmaceuticals. This doesn't necessarily mean it's not a good deal, but I am somewhat skeptical that it will lead to material revenues for Peregrine.<
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y